vs
Energy Services of America CORP(ESOA)与Ultragenyx Pharmaceutical Inc.(RARE)财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是Energy Services of America CORP的1.8倍($207.3M vs $114.1M),Ultragenyx Pharmaceutical Inc.同比增速更快(25.9% vs 13.4%),Energy Services of America CORP自由现金流更多($16.8M vs $-100.8M),过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高(38.0% vs 26.7%)
美国能源服务公司是一家美国能源服务控股企业,旗下拥有多个油气田设备租赁及油气井服务品牌,在油气能源服务领域开展相关业务。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业,专注于研发罕见病和超罕见遗传病的创新治疗方案,这类疾病目前大多无获批疗法,存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台,研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
ESOA vs RARE — 直观对比
营收规模更大
RARE
是对方的1.8倍
$114.1M
营收增速更快
RARE
高出12.5%
13.4%
自由现金流更多
ESOA
多$117.5M
$-100.8M
两年增速更快
RARE
近两年复合增速
26.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $114.1M | $207.3M |
| 净利润 | — | $-128.6M |
| 毛利率 | 12.3% | — |
| 营业利润率 | 4.3% | -54.7% |
| 净利率 | — | -62.0% |
| 营收同比 | 13.4% | 25.9% |
| 净利润同比 | — | 3.5% |
| 每股收益(稀释后) | $0.16 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ESOA
RARE
| Q4 25 | $114.1M | $207.3M | ||
| Q3 25 | $130.1M | $159.9M | ||
| Q2 25 | $103.6M | $166.5M | ||
| Q1 25 | $76.7M | $139.3M | ||
| Q4 24 | $100.6M | $164.6M | ||
| Q3 24 | $104.7M | $139.5M | ||
| Q2 24 | $85.9M | $147.0M | ||
| Q1 24 | $71.1M | $108.8M |
净利润
ESOA
RARE
| Q4 25 | — | $-128.6M | ||
| Q3 25 | — | $-180.4M | ||
| Q2 25 | — | $-115.0M | ||
| Q1 25 | — | $-151.1M | ||
| Q4 24 | — | $-133.2M | ||
| Q3 24 | — | $-133.5M | ||
| Q2 24 | — | $-131.6M | ||
| Q1 24 | — | $-170.7M |
毛利率
ESOA
RARE
| Q4 25 | 12.3% | — | ||
| Q3 25 | 12.6% | — | ||
| Q2 25 | 11.6% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 10.2% | — | ||
| Q3 24 | 16.8% | — | ||
| Q2 24 | 17.8% | — | ||
| Q1 24 | 8.8% | — |
营业利润率
ESOA
RARE
| Q4 25 | 4.3% | -54.7% | ||
| Q3 25 | 5.8% | -106.9% | ||
| Q2 25 | 3.1% | -64.8% | ||
| Q1 25 | -10.6% | -102.6% | ||
| Q4 24 | 1.6% | -74.3% | ||
| Q3 24 | 8.4% | -94.6% | ||
| Q2 24 | 9.9% | -79.1% | ||
| Q1 24 | -1.5% | -151.9% |
净利率
ESOA
RARE
| Q4 25 | — | -62.0% | ||
| Q3 25 | — | -112.8% | ||
| Q2 25 | — | -69.0% | ||
| Q1 25 | — | -108.5% | ||
| Q4 24 | — | -80.9% | ||
| Q3 24 | — | -95.7% | ||
| Q2 24 | — | -89.5% | ||
| Q1 24 | — | -156.8% |
每股收益(稀释后)
ESOA
RARE
| Q4 25 | $0.16 | $-1.28 | ||
| Q3 25 | $0.26 | $-1.81 | ||
| Q2 25 | $0.12 | $-1.17 | ||
| Q1 25 | $-0.41 | $-1.57 | ||
| Q4 24 | $0.05 | $-1.34 | ||
| Q3 24 | $0.40 | $-1.40 | ||
| Q2 24 | $1.06 | $-1.52 | ||
| Q1 24 | $-0.07 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $16.7M | $421.0M |
| 总债务越低越好 | $62.0M | — |
| 股东权益账面价值 | $60.6M | $-80.0M |
| 总资产 | $201.0M | $1.5B |
| 负债/权益比越低杠杆越低 | 1.02× | — |
8季度趋势,按日历期对齐
现金及短期投资
ESOA
RARE
| Q4 25 | $16.7M | $421.0M | ||
| Q3 25 | $12.2M | $202.5M | ||
| Q2 25 | $15.3M | $176.3M | ||
| Q1 25 | $9.9M | $127.1M | ||
| Q4 24 | $20.3M | $174.0M | ||
| Q3 24 | $12.9M | $150.6M | ||
| Q2 24 | $14.5M | $480.7M | ||
| Q1 24 | $12.1M | $112.3M |
总债务
ESOA
RARE
| Q4 25 | $62.0M | — | ||
| Q3 25 | $72.2M | — | ||
| Q2 25 | $59.1M | — | ||
| Q1 25 | $50.7M | — | ||
| Q4 24 | $59.6M | — | ||
| Q3 24 | $33.9M | — | ||
| Q2 24 | $31.9M | — | ||
| Q1 24 | $45.7M | — |
股东权益
ESOA
RARE
| Q4 25 | $60.6M | $-80.0M | ||
| Q3 25 | $59.2M | $9.2M | ||
| Q2 25 | $54.4M | $151.3M | ||
| Q1 25 | $53.7M | $144.2M | ||
| Q4 24 | $61.0M | $255.0M | ||
| Q3 24 | $58.7M | $346.8M | ||
| Q2 24 | $52.0M | $432.4M | ||
| Q1 24 | $34.6M | $140.3M |
总资产
ESOA
RARE
| Q4 25 | $201.0M | $1.5B | ||
| Q3 25 | $215.2M | $1.2B | ||
| Q2 25 | $189.1M | $1.3B | ||
| Q1 25 | $170.2M | $1.3B | ||
| Q4 24 | $192.1M | $1.5B | ||
| Q3 24 | $158.2M | $1.5B | ||
| Q2 24 | $148.8M | $1.6B | ||
| Q1 24 | $136.1M | $1.3B |
负债/权益比
ESOA
RARE
| Q4 25 | 1.02× | — | ||
| Q3 25 | 1.22× | — | ||
| Q2 25 | 1.09× | — | ||
| Q1 25 | 0.94× | — | ||
| Q4 24 | 0.98× | — | ||
| Q3 24 | 0.58× | — | ||
| Q2 24 | 0.61× | — | ||
| Q1 24 | 1.32× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $18.8M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $-100.8M |
| 自由现金流率自由现金流/营收 | 14.7% | -48.6% |
| 资本支出强度资本支出/营收 | 1.8% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $3.1M | $-472.0M |
8季度趋势,按日历期对齐
经营现金流
ESOA
RARE
| Q4 25 | $18.8M | $-99.8M | ||
| Q3 25 | $-9.3M | $-91.4M | ||
| Q2 25 | $3.4M | $-108.3M | ||
| Q1 25 | $1.1M | $-166.5M | ||
| Q4 24 | $8.9M | $-79.3M | ||
| Q3 24 | $-847.5K | $-67.0M | ||
| Q2 24 | $19.3M | $-77.0M | ||
| Q1 24 | $-2.7M | $-190.7M |
自由现金流
ESOA
RARE
| Q4 25 | $16.8M | $-100.8M | ||
| Q3 25 | $-12.0M | $-92.7M | ||
| Q2 25 | $-582.0K | $-110.7M | ||
| Q1 25 | $-1.1M | $-167.8M | ||
| Q4 24 | $6.0M | $-79.5M | ||
| Q3 24 | $-2.9M | $-68.6M | ||
| Q2 24 | $16.3M | $-79.0M | ||
| Q1 24 | $-4.9M | $-193.9M |
自由现金流率
ESOA
RARE
| Q4 25 | 14.7% | -48.6% | ||
| Q3 25 | -9.3% | -58.0% | ||
| Q2 25 | -0.6% | -66.5% | ||
| Q1 25 | -1.4% | -120.5% | ||
| Q4 24 | 5.9% | -48.3% | ||
| Q3 24 | -2.8% | -49.2% | ||
| Q2 24 | 18.9% | -53.7% | ||
| Q1 24 | -6.9% | -178.2% |
资本支出强度
ESOA
RARE
| Q4 25 | 1.8% | 0.5% | ||
| Q3 25 | 2.1% | 0.8% | ||
| Q2 25 | 3.9% | 1.5% | ||
| Q1 25 | 2.9% | 1.0% | ||
| Q4 24 | 2.9% | 0.1% | ||
| Q3 24 | 2.0% | 1.2% | ||
| Q2 24 | 3.6% | 1.4% | ||
| Q1 24 | 3.1% | 3.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESOA
| Electricals Mechanical And General | $49.4M | 43% |
| Gas And Petroleum Transmission | $24.1M | 21% |
| Cost Plus And TM Contracts | $23.3M | 20% |
| Transferred At Point In Time | $17.9M | 16% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |